Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postmarketing Surveillance Study for Use of Quadrivalent Influenza Vaccine (VaxigripTetra Inj.) Administered Via the Intramuscular Route in Subjects Aged 3 Years Old and Above in the Republic of Korea

NCT05406180 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT05406180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05406180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postmarketing Surveillance Study for Use of Quadrivalent Influenza Vaccine (VaxigripTetra Inj.) Administered Via the Intramuscular Route in Subjects Aged 3 Years Old and Above in the Republic of Korea
Lead sponsor
Sanofi
Phase
Observational
Overall status
Completed
Start date
October 10, 2018
Completion date
December 27, 2019
Enrollment
675 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

influenza